In particular, we assessed CD73 in metastatic lesions only, and our cohort is biased towards a subset of melanoma patients who subsequently develop metastatic melanoma, meaning that among the cases with lower Breslow's depth only the minority with an unfavorable outcome was selected. Here, NT5E is linked to melanoma.